Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
IL31RA
Introduction
Interleukin-31 receptor A is a protein that in humans is encoded by the IL31RA gene.[1][2][3]
IL31RA is related to gp130 (IL6ST; MIM 600694), the common receptor subunit for IL6 (MIM 147620)-type cytokines. Oncostatin M receptor (OSMR; MIM 601743) and IL31RA form the heterodimeric receptor through which IL31 (MIM 609509) signals. Expression of IL31RA and OSMR mRNA is induced in activated monocytes, and both mRNAs are constitutively expressed in epithelial cells (Dillon et al., 2004).[supplied by OMIM][3]
References
References
- ↑ Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA (Jun 2004). “Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice”. Nat Immunol. 5 (7): 752–60. doi:10.1038/ni1084. PMID 15184896.
- ↑ Ghilardi N, Li J, Hongo JA, Yi S, Gurney A, de Sauvage FJ (May 2002). “A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5”. J Biol Chem. 277 (19): 16831–6. doi:10.1074/jbc.M201140200. PMID 11877449.
- ↑ 3.0 3.1 “Entrez Gene: IL31RA interleukin 31 receptor A”.
Further reading
Further reading
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). “The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment”. Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
- Diveu C, Lelièvre E, Perret D, et al. (2004). “GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor”. J. Biol. Chem. 278 (50): 49850–9. doi:10.1074/jbc.M307286200. PMID 14504285.
- Dreuw A, Radtke S, Pflanz S, et al. (2005). “Characterization of the signaling capacities of the novel gp130-like cytokine receptor”. J. Biol. Chem. 279 (34): 36112–20. doi:10.1074/jbc.M401122200. PMID 15194700.
- Zhang Z, Henzel WJ (2005). “Signal peptide prediction based on analysis of experimentally verified cleavage sites”. Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Diveu C, Lak-Hal AH, Froger J, et al. (2005). “Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling”. Eur. Cytokine Netw. 15 (4): 291–302. PMID 15627637.
- Bilsborough J, Leung DY, Maurer M, et al. (2006). “IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis”. J. Allergy Clin. Immunol. 117 (2): 418–25. doi:10.1016/j.jaci.2005.10.046. PMID 16461143.